# Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population

> **NCT00641784** · PHASE3 · TERMINATED · sponsor: **MemorialCare** · enrollment: 200 (estimated)

## Conditions studied

- Labor, Premature

## Interventions

- **DRUG:** Magnesium
- **DRUG:** Nifedlipine

## Key facts

- **NCT ID:** NCT00641784
- **Lead sponsor:** MemorialCare
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641784, "Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00641784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*